Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lalpath Labs has informed that it has enclosed the details of proposed schedule of Analyst/Institutional Investor meeting(s) that will be held on 3rd June 2021. Dates of the meeting/call are subject to change due to exigencies on the part of Investor/Company. No Unpublished Price Sensitive Information will be shared during the meetings.
The above information is a part of company’s filings submitted to BSE.
